Lamotrigine Discontinuation Guidelines

Introduction to Tapering

• The American College of Neurology recommends that lamotrigine should never be stopped abruptly and requires gradual dose reduction over 2-4 weeks to minimize withdrawal symptoms and prevent seizure recurrence 1

Evidence for Gradual Tapering

• The standard tapering protocol involves gradually reducing lamotrigine over 2-4 weeks, as recommended by major clinical practice guidelines 1
• For patients who have achieved seizure control after near-gross total resection of brain tumors, efforts at tapering and stopping anticonvulsant drugs should be undertaken within weeks after surgery, but this still implies a gradual process rather than abrupt discontinuation 2

Clinical Scenarios for Discontinuation

• In brain tumor patients with epilepsy who undergo successful near-gross total resection and have no recurrent tumor growth, tapering can be considered within weeks after surgery 2
• When switching from lamotrigine to another anticonvulsant, cross-titration over 2-4 weeks is recommended, with simultaneous gradual reduction of lamotrigine while initiating the new agent 1

Important Caveats

• Never restart lamotrigine at the full previous dose after any period of discontinuation; instead, re-titration from the beginning starting at a low dose is required to minimize the risk of serious rash 3
• The risk of serious rash necessitates strict adherence to slow titration schedules both when starting and restarting the medication 3

Restarting Lamictal After a Discontinuation

Critical Safety Principle

• The American Academy of Emergency Medicine suggests that lamotrigine can only be reloaded at 6.5 mg/kg as a single dose if the patient has been off the medication for less than 5 days, has been on lamotrigine for more than 6 months, and has no history of rash or intolerance 4, 5

Adverse Effects to Monitor

• Headache, nausea, and dizziness are common adverse effects to monitor when restarting lamotrigine 5